Congenital Mesoblastic Nephroma in a Premature Neonate: Should We Give Adjuvant Chemotherapy? | Zendy

Nahla Kechiche | Zendy; Dorsaf Makhlouf | Zendy; Samia Belhassen | Zendy; Nahla Hmidi | Zendy; Lamiri Rachida | Zendy; Mekki Mongi | Zendy; Belguith Mohssen | Zendy; Nouri Abdellatif | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Congenital Mesoblastic Nephroma in a Premature Neonate: Should We Give Adjuvant Chemotherapy?

Author(s) -

Nahla Kechiche,

Dorsaf Makhlouf,

Samia Belhassen,

Nahla Hmidi,

Lamiri Rachida,

Mekki Mongi,

Belguith Mohssen,

Nouri Abdellatif

Publication year - 2019

Publication title -

journal of neonatal surgery

Language(s) - English

Resource type - Journals

ISSN - 2226-0439

DOI - 10.47338/jns.v8.242

Subject(s) - medicine , nephrectomy , adjuvant chemotherapy , chemotherapy , surgery , adjuvant therapy , adjuvant , renal tumor , kidney , cancer , breast cancer

Congenital mesoblastic nephroma (CMN) is a rare renal tumor of infancy. Complete surgical excision is often sufficient. A premature neonate underwent left radical nephrectomy for CMN without any adjuvant therapy. Pathology was consistent with cellular type CMN. Six months postoperatively, the patient developed recurrence. He subsequently underwent re-excision without any adjuvant chemotherapy. The baby is tumor free for more than a year.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research